4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0000950170-24-026996
Options or other derivatives
- Chief Financial Officer acquired 235,000 shares (grant or award)
From the SEC's structured data for this filing
Bolt Biotherapeutics, Inc. Filed Acc 0000950170-24-026996
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…